Literature DB >> 3114651

Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.

D Hovevey-Sion, J P Finberg.   

Abstract

Rats were treated once (acute) or once daily for 21 days (chronic) with clorgyline (2 mg/kg) or nialamide (50 mg/kg). (-)Deprenyl (1 mg/kg) was given for 21 days. One day after the last injection, vas deferens and anococcygeus muscles were removed and noradrenaline stores labelled with 3H-noradrenaline. Efflux of total tritium following electrical field stimulation was decreased by both acute and chronic treatment with clorgyline and nialamide, as well as by chronic treatment with deprenyl. Total tritium release from anococcygeus muscle was reduced by both acute and chronic treatment with clorgyline. Fractionation of the effluent showed that release of both free noradrenaline and metabolites was decreased by MAO inhibitor treatment in vivo, but this effect was not reproduced by in vitro incubation of the vas deferens with clorgyline (1 microM). By contrast to the effect of electrical field stimulation, release of 3H-noradrenaline induced by veratrine was increased by chronic treatment with both clorgyline and nialamide. Release of total tritium by depolarising concentrations of KCl was also increased by chronic clorgyline treatment. These results could be explained by a proportionally greater release of tritium from a cytoplasmic compartment following veratrine and KCl than electrical stimulation, since MAO inhibition increases cytoplasmic noradrenaline levels. Alternatively, release by electrical stimulation may be affected to a greater extent by presynaptic alpha 2-adrenoceptors, and presynaptic receptors may be stimulated by increased synaptic levels of free noradrenaline following MAO inhibition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114651     DOI: 10.1007/bf00177753

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain.

Authors:  M M Sellinger-Barnette; J Mendels; A Frazer
Journal:  Neuropharmacology       Date:  1980-05       Impact factor: 5.250

2.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

3.  The influence of intraneuronal monoamine oxidase on neuronal net uptake of noradrenaline and on sensitivity to noradrenaline.

Authors:  U Trendelenburg; P R Draskóczy; K H Graefe
Journal:  Adv Biochem Psychopharmacol       Date:  1972

4.  Saturation of monoamine oxidase by intraneuronal noradrenaline accumulation.

Authors:  F J Stefano; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

5.  [3H]noradrenaline release from brain slices induced by an increase in the intracellular sodium concentration: role of intracellular calcium stores.

Authors:  A N Schoffelmeer; A H Mulder
Journal:  J Neurochem       Date:  1983-03       Impact factor: 5.372

6.  The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat.

Authors:  S Z Langer
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

7.  Effect of desipramine and cocaine on plasma norepinephrine and pressor responses to adrenergic stimulation in pithed rats.

Authors:  M A Bayorh; Z Zukowska-Grojec; I J Kopin
Journal:  J Clin Pharmacol       Date:  1983-01       Impact factor: 3.126

8.  Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.

Authors:  M M Caramona; D Araújo; F Brandão
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

9.  Chronic clorgyline treatment enhances release of norepinephrine following sympathetic stimulation in the rat.

Authors:  J P Finberg; I J Kopin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

10.  The effects of nialamide on adrenergic functions.

Authors:  M J DAVEY; J B FARMER; H REINERT
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  1 in total

1.  Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.

Authors:  J P Finberg; K Pacak; I J Kopin; D S Goldstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.